Brett K Haumann - Net Worth and Insider Trading
Brett K Haumann Net Worth
The estimated net worth of Brett K Haumann is at least $3 Million dollars as of 2024-11-13. Brett K Haumann is the Chief Medical Officer of Theravance Biopharma Inc and owns about 282,810 shares of Theravance Biopharma Inc (TBPH) stock worth over $3 Million. Details can be seen in Brett K Haumann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brett K Haumann has not made any transactions after 2020-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brett K Haumann
Brett K Haumann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brett K Haumann owns 2 companies in total, including Aimmune Therapeutics Inc (AIMT) , and Theravance Biopharma Inc (TBPH) .
Click here to see the complete history of Brett K Haumann’s form 4 insider trades.
Insider Ownership Summary of Brett K Haumann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-10 | director |
| TBPH | Theravance Biopharma Inc | 2020-08-21 | VP-Clinical Develop. |
Brett K Haumann Latest Holdings Summary
Brett K Haumann currently owns a total of 1 stock. Brett K Haumann owns 282,810 shares of Theravance Biopharma Inc (TBPH) as of August 21, 2020, with a value of $3 Million.
Latest Holdings of Brett K Haumann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2020-08-21 | 282,810 | 8.91 | 2,519,837 |
Holding Weightings of Brett K Haumann
Brett K Haumann Form 4 Trading Tracker
According to the SEC Form 4 filings, Brett K Haumann has made a total of 1 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Theravance Biopharma Inc is the sale of 25,000 shares on August 21, 2020, which brought Brett K Haumann around $457,250.
Insider Trading History of Brett K Haumann
- 1
Brett K Haumann Trading Performance
Brett K Haumann Ownership Network
Ownership Network List of Brett K Haumann
Ownership Network Relation of Brett K Haumann
Brett K Haumann Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Brett K Haumann is the director of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Brett K Haumann Mailing Address
Above is the net worth, insider trading, and ownership report for Brett K Haumann. You might contact Brett K Haumann via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
